---
$id: https://graph.org.ai/products/commodity/51282901
$type: Product
source: UNSPSC
code: "51282901"
title: "Cinoxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinoxacin

**UNSPSC Code**: 51282901
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C12H10N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LMK22VUH23, chemically known as 1-ethyl-6,7-methylenedioxy-4(1h)-oxocinnoline-3-carboxylic acid but generally known as cinoxacin, which bears US NIH Compound Identifier 2762. European Medicines Agency schedules Cinoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06309MIG. The term CINOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules cinoxacin in its Anatomical Therapeutic Chemical (ATC) Classification. CINOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinoxacin under HS 29349990 and SITC 51579. As of Q4 2014, CINOXACIN remains the US FDA Preferred Term for this commodity. Cinoxacin bears US NLM identifiers UMLS ID C0008806 and NCI Concept Code C65333. SMILES: CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3.

